BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9560298)

  • 1. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix.
    Kafienah W; Brömme D; Buttle DJ; Croucher LJ; Hollander AP
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):727-32. PubMed ID: 9560298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of native type I collagen by human neutrophil elastase.
    Kafienah W; Buttle DJ; Burnett D; Hollander AP
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):897-902. PubMed ID: 9480907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K.
    Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J
    Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early cathepsin K degradation of type II collagen in vitro and in vivo in articular cartilage.
    Mort JS; Beaudry F; Théroux K; Emmott AA; Richard H; Fisher WD; Lee ER; Poole AR; Laverty S
    Osteoarthritis Cartilage; 2016 Aug; 24(8):1461-9. PubMed ID: 27049030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The collagenolytic activity of cathepsin K is unique among mammalian proteinases.
    Garnero P; Borel O; Byrjalsen I; Ferreras M; Drake FH; McQueney MS; Foged NT; Delmas PD; Delaissé JM
    J Biol Chem; 1998 Nov; 273(48):32347-52. PubMed ID: 9822715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity.
    Lecaille F; Choe Y; Brandt W; Li Z; Craik CS; Brömme D
    Biochemistry; 2002 Jul; 41(26):8447-54. PubMed ID: 12081494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen.
    Steffensen B; Wallon UM; Overall CM
    J Biol Chem; 1995 May; 270(19):11555-66. PubMed ID: 7744795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Clostridium histolyticum collagenase hyperreactive sites in type I, II, and III collagens: lack of correlation with local triple helical stability.
    French MF; Bhown A; Van Wart HE
    J Protein Chem; 1992 Feb; 11(1):83-97. PubMed ID: 1325154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope.
    Atley LM; Mort JS; Lalumiere M; Eyre DR
    Bone; 2000 Mar; 26(3):241-7. PubMed ID: 10709996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin D: specificity of peptide-bond cleavage in type-I collagen and effects on type-III collagen and procollagen.
    Scott PG; Pearson H
    Eur J Biochem; 1981; 114(1):59-62. PubMed ID: 6783404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cathepsin L, a papain-like collagenase without proline specificity.
    Korenč M; Lenarčič B; Novinec M
    FEBS J; 2015 Nov; 282(22):4328-40. PubMed ID: 26306868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The purification of bovine cathepsin B1 and its mode of action on bovine collagens.
    Etherington DJ
    Biochem J; 1974 Mar; 137(3):547-57. PubMed ID: 4423493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flexibility of the α2 chain of type I collagen on collagenase cleavage.
    Mekkat A; Poppleton E; An B; Visse R; Nagase H; Kaplan DL; Brodsky B; Lin YS
    J Struct Biol; 2018 Sep; 203(3):247-254. PubMed ID: 29763735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular-matrix degradation at acid pH. Avian osteoclast acid collagenase isolation and characterization.
    Blair HC; Teitelbaum SL; Grosso LE; Lacey DL; Tan HL; McCourt DW; Jeffrey JJ
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):873-84. PubMed ID: 8457215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin B1. A lysosomal enzyme that degrades native collagen.
    Burleigh MC; Barrett AJ; Lazarus GS
    Biochem J; 1974 Feb; 137(2):387-98. PubMed ID: 4207388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of collagenolytic cathepsins by beta-lactoglobulin in milk and its suppressive effect on bone resorption.
    Ogawa N; Takahashi M; Ishidoh K; Katunuma N
    J Nutr Sci Vitaminol (Tokyo); 2009 Jun; 55(3):264-70. PubMed ID: 19602835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for interstitial collagen catabolism by mammalian collagenases.
    Fields GB
    J Theor Biol; 1991 Dec; 153(4):585-602. PubMed ID: 1666905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate.
    Li Z; Hou WS; Escalante-Torres CR; Gelb BD; Bromme D
    J Biol Chem; 2002 Aug; 277(32):28669-76. PubMed ID: 12039963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I collagen N-telopeptides adopt an ordered structure when docked to their helix receptor during fibrillogenesis.
    Malone JP; George A; Veis A
    Proteins; 2004 Feb; 54(2):206-15. PubMed ID: 14696182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage.
    Dejica VM; Mort JS; Laverty S; Percival MD; Antoniou J; Zukor DJ; Poole AR
    Am J Pathol; 2008 Jul; 173(1):161-9. PubMed ID: 18511517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.